BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million

Reuters

02-25

BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million

Feb 25 (Reuters) - Elanco Animal Health Q4 adjusted EBITDA USD 177 million vs. IBES estimate USD 179.7 million.

Q4 adjusted net income USD 72 million vs. IBES estimate USD 74.9 million
outlook FY revenue USD 4,445-4,510 million
outlook FY adjusted EPS USD 0.8-0.86
outlook FY net income USD -25 to 7 million
outlook FY adjusted EBITDA USD 830-870 million

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2514214098"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514214098\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2514214098?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-25 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514214098","market":"us","top_or_hot":-1,"title":"BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million</title>\n</head>\n<body>\n<p>Feb 25 (Reuters) - Elanco Animal Health Q4 adjusted EBITDA USD 177 million vs. IBES estimate USD 179.7 million.</p>\n<ul>\n<li>Q4 adjusted net income USD 72 million vs. IBES estimate USD 74.9 million</li>\n<li>outlook FY revenue USD 4,445-4,510 million</li>\n<li>outlook FY adjusted EPS USD 0.8-0.86</li>\n<li>outlook FY net income USD -25 to 7 million</li>\n<li>outlook FY adjusted EBITDA USD 830-870 million</li>\n</ul>\n</body>\n</html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-02-25 20:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<meta/>\n<title>BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million</title>\n<p>Feb 25 (Reuters) - Elanco Animal Health Q4 adjusted EBITDA USD 177 million vs. IBES estimate USD 179.7 million.</p>\n<ul>\n<li>Q4 adjusted net income USD 72 million vs. IBES estimate USD 74.9 million</li>\n<li>outlook FY revenue USD 4,445-4,510 million</li>\n<li>outlook FY adjusted EPS USD 0.8-0.86</li>\n<li>outlook FY net income USD -25 to 7 million</li>\n<li>outlook FY adjusted EBITDA USD 830-870 million</li>\n</ul>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELAN","symbol_name":"Elanco Animal Health Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nPLX4705C0:1","article_id":"2514214098","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514214098","pubTimestamp":1740485152,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Feb 25  - Elanco Animal Health Q4 adjusted EBITDA USD 177 million vs. IBES estimate USD 179.7 million.Q4 adjusted net income USD 72 million vs. IBES estimate USD 74.9 million","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ELAN":"Elanco Animal Health Inc"},"translate_title":"简介-Elanco Animal Health第四季度收入为10.2亿美元，而IBES预估为10.1亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":0.9},"content_text":"BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million\n\n\nFeb 25 (Reuters) - Elanco Animal Health Q4 adjusted EBITDA USD 177 million vs. IBES estimate USD 179.7 million.\n\nQ4 adjusted net income USD 72 million vs. IBES estimate USD 74.9 million\noutlook FY revenue USD 4,445-4,510 million\noutlook FY adjusted EPS USD 0.8-0.86\noutlook FY net income USD -25 to 7 million\noutlook FY adjusted EBITDA USD 830-870 million","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}